TY - JOUR
T1 - EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators
T2 - Endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart RhythmSociety (APHRS), and the Latin-American Heart RhythmSociety (LAHRS)
AU - Burri, Haran
AU - Starck, Christoph
AU - Auricchio, Angelo
AU - Biffi, Mauro
AU - Burri, Mafalda
AU - D'avila, Andre
AU - Deharo, Jean Claude
AU - Glikson, Michael
AU - Israel, Carsten
AU - Lau, Chu Pak
AU - Leclercq, Christophe
AU - Love, Charles J.
AU - Nielsen, Jens Cosedis
AU - Vernooy, Kevin
AU - Dagres, Nikolaos
AU - Boveda, Serge
AU - Butter, Christian
AU - Marijon, Eloi
AU - Braunschweig, Frieder
AU - Mairesse, Georges H.
AU - Gleva, Marye
AU - Defaye, Pascal
AU - Zanon, Francesco
AU - Lopez-Cabanillas, Nestor
AU - Guerra, Jose M.
AU - Vassilikos, Vassilios P.
AU - Oliveira, Mario Martins
N1 - Funding Information:
Conflict of interest: A.A. is a consultant to Boston Scientific, Backbeat, Biosense Webster, Cairdac, Corvia, Microport CRM, EPD-Philips, Radcliffe Publisher. He received speaker fees from Boston Scientific, Medtronic, and Microport. He participates in clinical trials sponsored by Boston Scientific, Medtronic, EPD-Philips. He has intellectual properties with Boston Scientific, Biosense Webster, and Microport CRM. H.B. has received speaker honoraria from Biotronik and Medtronic and has received institutional fellowship support and research grants from Abbott, Biotronic, Boston Scientific, Medtronic, and Microport. J.-C.D. declares honoraria for lectures, research and travel grants from Abbott, Biotronik, Boston Scientific, Medtronic, Microport. C.J.L. is a consultant to Medtronic and Philips Medical, and has received honoraria from Convatec and Abbott Medical, and research support from Boston Scientific. C.S. declares payment to his institution related to his activity as speaker fees, honoraria, consultancy, advisory board fees, investigator, committee member from Angiodynamics, Medtronic, Spectranetics, Biotronik, Liva Nova (Sorin) and Cook Medical and departmental or institutional research funding from Cook Medical. K.V. is consultant for Medtronic and Abbott. None of the other authors report any conflicts of interest.
Publisher Copyright:
© 2021 Oxford University Press. All rights reserved.
PY - 2021
Y1 - 2021
N2 - With the global increase in device implantations, there is a growing need to train physicians to implant pacemakers and implantable cardioverter-defibrillators. Although there are international recommendations for device indications and programming, there is no consensus to date regarding implantation technique. This document is founded on a systematic literature search and review, and on consensus from an international task force. It aims to fill the gap by setting standards for device implantation. All rights reserved. VC The Author(s) 2021. For permissions.
AB - With the global increase in device implantations, there is a growing need to train physicians to implant pacemakers and implantable cardioverter-defibrillators. Although there are international recommendations for device indications and programming, there is no consensus to date regarding implantation technique. This document is founded on a systematic literature search and review, and on consensus from an international task force. It aims to fill the gap by setting standards for device implantation. All rights reserved. VC The Author(s) 2021. For permissions.
KW - Consensus document
KW - Implantable cardioverter-defibrillator
KW - Implantation
KW - Pacemaker
KW - Recommendations
UR - http://www.scopus.com/inward/record.url?scp=85111477358&partnerID=8YFLogxK
U2 - 10.1093/europace/euaa367
DO - 10.1093/europace/euaa367
M3 - Article
C2 - 33878762
AN - SCOPUS:85111477358
VL - 23
SP - 983
EP - 1008
JO - Europace
JF - Europace
SN - 1099-5129
IS - 7
ER -